TRDA logo
Entrada Therapeutics, Inc.(TRDA)
$5.38—

Russell 2000 below the 50-day average

Overview →

TRDA News

About

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Leadership (9)
Kevin HealySenior Vice President of Regulatory Affairs
Sandeep BasnetHead of Information Technology
Jared CohenGeneral Counsel
Natarajan SethuramanPresident of Research & Development
Dipal DoshiChief Executive Officer & Director
Kerry RobertSenior Vice President of People
Nathan J. DowdenPresident & Chief Operating Officer
Karla MacDonaldChief Corporate Affairs Officer
Kory James WentworthChief Financial Officer & Treasurer
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.